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INTRODUCTION 
" ••• the embryo is a mosaic of sensitivities, some organs, tissues 
and cells being sensitive at one moment while others, later to be sen-
sitive, are resistant." (Rugh et al., 1964) 
The assessment of elements which present environmental hazards 
includes a clarification of their effects on the un-born. These areas 
of research, teratology and toxicology, attempt to discriminate among 
the malformations occurring in the development of organisms those vari-
ations induced by manipulation of the embryonic milieu. Of ecological 
importance are the possible alterations of normal gestation periods a-
rising from polluted sources of food, water or air. The presence of 
detergent and detergent by-products in the environment constitutes such 
a potential danger to the normal existence and reproduction of both do-
mesticated and wild life. 
The purpose of this thesis is the presentation of results obtained 
in an investigation of a surfactant component of biodegradeable deter-
gents, linear alkylbenzene sulfonate (LAS). The study was designed to 
elucidate the existing evidence concerning the potential teratogenic/ 
toxic action of LAS. Introduction of the surfactant into the peritoneal 
cavity of pregnant mice was the adopted experimental method. The ICR-CD-
1 strain of mice was selected to represent mammalian responses to LAS for 
two reasons, the first being the facilitation of result comparisons with 
other, related studies. A second factor is the ease of acquiring data 
from an organism which exhibits short gestation periods and provides 
large litters for examination. 
In consideration of the un-perceived interactions feasible in the 
1 
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maturation process of the mauunalian embryo, it is hoped that interpreters 
will exercise careful judgment in relating the findings reported here to 
physiological mechanisms and consequences. 
REVIEW OF THE RELATED LITERATURE 
The first soap manufacturers, producing cleansers similar to 
those found now, are thought to have carried out the synthesis by dripping 
goat tallow onto the ashes of wood-fires, presumably during the era of 
Julius Caesar (Morrison and Boyd, 1972). This process, although modi-
fied by technological advancements and industrial innovations, is unal-
tered in its types of reactants and the cleansing properties of its 
products from the general equation used for the manufacture of soaps and 
detergents today. Invariably, this reaction involves the break-down of 
a fat into the metallic salts of carboxylic acids (soaps) with an alco-
hol, glycerol, as a by-product (Hart and Schuetz, 1972). If the addition 
of water causes the fat reduction, the reaction is termed a hydrolysis; 
usually, in the formation of soap, a base, such as sodium hydroxide, is 
utilized and the process is known as saponification (Routh, 1971). 
Two drawbacks associated with soap usage have resulted in their 
major displacement on the market by synthetic products, the detergents. 
The first disadvantage of soaps is that they cannot function well in 
acid mediums due to the carboxylic acid in their structure (Shaw, 1966); 
the second problem is that in "hard" water, the calcium and magnesium 
ions present will react with the polar portion of the soap molecule, re-
placing the sodium ion and forming insoluble salts which decrease the 
efficiency of the washing process (Hart and Schuetz, 1972). Synthetic 
detergents have been designed to overcome both of these difficulties by 
introducing a sulf onate group (S03H) at the polar end of the molecule 
which inhibits such insoluble precipitates from forming (Morrison and 
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Boyd, 1972). 
The detergent industry has grown to vast proportions in a rela-
tively short period of time (Schwartz et al., 1958). In spite of the 
great varieties of detergents manufactured, however, all preparations 
have one significant physical property in common that is responsible 
for their chemical effect of cleaning matter: they are amphipathic 
(Vold and Vold, 1964). This term refers to the structural formation of 
detergents, indicating that there are both hydrophilic (water-soluble) 
and lipophilic (oil-soluble) portions present. It is through the com-
bination of such polar and non-polar properties that detergents derive 
their cleansing activity (Bennett et al., 1968). 
4 
These amphipathic compounds are termed association ~olloids; 
"substances whose molecules aggregate spontaneously in a given solvent 
to form thermodynamically stable particles of colloidal dimensions" 
(Vold and Vold, 1964). Such association colloids are distinguished from 
lyophilic, or true solutions, and lyophobic (liquid-hating) ones in that 
the characteristics of both types of suspensions are found in one mol-
ecule (Levitt, 1967) which results in the distinctive reaction of deter-
gents upon dirt (matter out of place) (Schwartz et al., 1958). 
This reactivity of detergents is integrally related to their 
physical conformation at the surface of a liquid; consequently, they are 
known as surface-active-agents, which has been commonly abbreviated to 
the term surfactant (Schwartz et al., 1958). In a liquid that contains 
an amphipathic substance, there is an energetically favorable tendency 
to congregate at the inter-face of the medium (Mysels et al., 1959). 
With such an arrangement, the polar parts of the molecule can organize 
themselves so as to be ionically-involved with the aqueous solvent and 
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the hydrophobic ends can project away from such contact. One result 
from such an orientation is a lowering of the surface tension -0f the 
solvent (Shaw, 1966); another effect is the greater tendency for bubbles 
and foam to be produced (Swisher, 1970). 
Besides their potential for removing dirt from material, surfac-
tants exhibit two other properties arising from their colloidal nature. 
The first of these is to.form micelles above a certain concentration in 
solution, called the critical micelle concentration (cmc) (Swisher, 1970). 
Below the cmc, soap or detergent molecules are individually present, but 
owing to the "cooperative phenomenon" of micellization, once the cmc is 
reached, the aggregates form abruptly (Vold and Vold, 1964). 
The second colloidal characteristic of detergents is particularly 
significant in any determination of the concentration of surfactant 
present in a medium (e.g., biodegradation measurements). Because of the 
-marked aggregation of the molecules at the boundaries of the solvent, an 
assessment of the particles present merely in the body of the liquid will 
result in a lower value than the actual concentration. This same pro-
perty implies that the sides or walls of any vessel will have proportion-
ally more surfactant molecules than the interior; accurate measurements 
require adjustments for the presence of this peculiarity (Swisher, 1970). 
Surfactants can be sub-divided into three categories on the basis 
of their reactions in aqueous solutions. One group, the anionic deter-
gents, form ions in which the lipophilic portion is negatively charged 
and the polar part of the molecule has a positive charge (i.e., Na+ -so3R) 
(Swisher, 1970). The anionic surfactants compose the largest percentage 
(50%) of detergents manufactured presently (Levitt, 1967). The second 
type of surfactant preparations are cationic; in aqueous solutions, the 
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hydrophilic end of the molecule bears the negative charge with the non-
polar group exhibiting the positive one. The final class, the non~ionic 
surfactants, contain molecules which are ionically neutral and derive 
their soap-like properties from the abundance of oxygen atoms (which will 
bind with hydrogen atoms) in their side chairis (Morrison and Boyd, 1972). 
Since the waste products of detergent usage are normally accumu-
lated in sewage waters, a term which has achieved much attention since 
the surfactant industrial revolution is biodegradability. This express-
ion refers to the degree to which bacteria can break down the chemical 
structure of a compound through the process of oxidation (Schwartz et al., 
1958). There are two forms of this process: primary biodegradation, 
which results in partially degraded compounds which have l.ost their sur-
factancy properties, and ultimate biodegradation in which there is 
"complete conversion of surfactant molecules_ to co2 , HzO, inorganic salts 
and products associated with the "normal" metabolic process of bacteria" 
(Swisher, 1970). 
Bacteria utilize an astounding array of organic compounds as their 
nutrients; the introduction of a surfactant into sewage waters, treat-
ment plants and rivers, results in an acclimation of the bacterial in-
habitants to the altered diet. The problem of detergency disposal, then, 
pertains to the various relative rates at which bacteria can adjust 
themselves to a surfactant's structural identity with its subsequent 
oxidation (Swisher, 1970). 
When the explosive adaptation from soaps to detergents was occur-
ring, one of the major surfactants on the market was tetrapropylene 
alkylbenzene sulfonate (TBS). Because of the multiple branching assoc-
iated with its carbon·chain, however, bacteria were unable to digest the 
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surfactant in a reasonable time and the presence of TBS became detectable 
in significantly pollutive amounts. Noticeable traces were even found 
in the drinking water supplies of some communities (Levitt, 1967). For 
this reason, TBS was designated as un-biodegradable; its current role 
in detergent operations has been greatly reduced, with the linear alkyl-
benzene sulfonate (LAS) detergents. now the leading surfactants (Pattison, 
1967; Morrison and Boyd, 1972). 
Since the experience of TBS, the detergent industry has found it 
necessary to adopt measures which determine the biodegradation rates of 
their products (Mccutcheon, 1967; Sullivan and Evans, 1968; Halvorson 
and Ishaque, 1969; Sullivan and Swisher, 1969). One method used to 
trace surfactants' biodegradation rates is throug? the use of methylene 
blue active substances (MBAS). The dye, methylene blue, serves as an 
indicator of the amount of surfactancy present in a liquid; its estab-
lished sensitivity (based on color change) contributes to its widespread 
usage in detergency analysis (Haney et al., 1954). In addition, in 1962, 
the U.S. Public Health Service Drinking Water Standards imposed an upper 
limit of 0.5 parts per million (ppm) as the concentration of anionic 
surfactants permitted in environmental waters (Pattison, 1967; Swisher, 
1968). 
In a series of investigations Swisher (1963) demonstrated the 
rapid biodegradation rates of the LAS detergents in river water and noted 
some important consequences of the various homologs' chemical structures. 
Increasing the distance between the hydrophobic end and the sulfonate 
group was found to accelerate biodegrada~ion as did decreasing the branch-
ing of the lipophilic portion. Biodegradation rates decreased with 
carbon chain lengths greater than 12, although such tendencies were 
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reduced by an elevation of pH and temperature. Swisher concluded that 
biodegradation involved an orientation of the sulfonate group with 
respect to the enzyme site of the reaction, the oxidation rate depending 
upon the distance thus established. 
In other experiments, several commercial LAS preparations with a 
range of hydrocarbon chain lengths (11,12,13) were rapidly degraded by 
mixed cultures of bacteria existing in a sewage lagoon (Halvorson and 
Ishaque, 1969). The organisms were unable to metabolize TBS, nor could 
they degrade the LAS compounds if the temperature was lowered to 2° C1 
or if anaerobic testing conditions were implemented. 
Although the sales of synthetic detergents continued to increase, 
the nation-wide substitution of linear-type compounds for the branched 
forms (1965) was accompanied by falling levels of MBAS as measured in 
the Illinois River (Sullivan and Evans, 1968). Follow-up studies showed 
that the MBAS content of this major water-way continued to drop; by 
1968, its concentration was determined as less than 0.05 mg/liter (Sull-
ivan and Swisher, 1969). 
In spite of the confident implications of such reports, the con-
troversy concerning the safe utilization of LAS with its ultimate trans-
ference to waste systems has not been settled. The uncertainty, how-
ever, centers not around the biodegradation rate, but the toxicity of 
LAS surfactants towards organisms which reside in LAS-deposited waters 
or receive their drinking-water supply from such sources. Moreover, 
residues of LAS products may remain on anim~l hardware, cooking utensils 
or edible products; contact exposure can arise through normal usage, 
accidental mis-application or from clothing. 
Investigations with goldorfen (Hirsh, 1963), bluegill, fingerlings 
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(Swisher et al., 1964) and guppies (Borstlap, 1967) provided information 
concerning -the toxicity of LAS to aquatic vertebrates. These studies 
reported that the toxic properties of LAS preparations became more 
pronounced as the linearity of the alkyl chain increased or the phenyl 
group approached the terminal end of the molecule. Moreover, variations 
of lethality occurred with the number of carbon atoms on the alkyl chain. 
At comparable concentrations, the homologs greater than C12 were more 
toxic than shorter chain length compounds. Additional tests demonstrated 
that the order of toxicity was greatly reduced for biodegraded inter-
mediates of LAS (Swisher et al., 1964; Borstlap, 1967). 
In his experiments with the mosquito minnow, Dooley (1968) found 
that 0.1% solutions of LAS were toxic to fish within 17 minutes and 
survival times increased with serial dilutions of the test material. 
Dooley also noted that females withstood LAS concentrations that were 
lethal to males, while younger fish were more sensitive than mature ones 
to LAS-exposure. 
Additional evidence of age bearing a relationship to susceptibil-
ity to LAS came from the work of Hokanson and Smith (1971). These 
investigators found that the bluegill feeding sac-fry demonstrated the 
least resistance to LAS, while eggs and fingerlings were intermediately 
affected and newly hatched sac-fry were the most tolerant group. The 
authors also estimated that a ·concentration of 1.0 mg LAS/liter would 
provide a margin of safety for bluegills of the Mississippi River, 
assuming a minimal degree of biodegradation was occurring. 
Another avenue of LAS research is the effect of such agents upon 
mammalian systems. Hopper et al. (1949) investigated the acute toxicity 
of several surfactant compounds including dodecyl benzene sodium sulfon-
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ate (santomerse 3) to Harlan albino mice by intravenous injection and 
oral intubation. A lethal dose to 1/2 of the test animals (LD50).with-
in a pre-determined time limit was measured for both routes of dose 
administration. After 24 hours, the intravenous LD50 was recorded as 
105 mg LAS/kg body weight, while the oral LD50 (after 72 hours) was 
2000 mg LAS/kg. 
Synder et al., (1964) arrived at even higher acute toxicity 
values in their study of "complete" household detergents. Using Webster 
mice which had been deprived of food for 16 hours prior to intubation, 
they obtained the following results: for Detergent Type 1 (LAS), an 
LD50 of 2200-4600 mg/kg; for Detergent Type 2 (equal parts LAS and 
sodium alkyl sulfate), an LD50 of 3800-7500 mg/kg. However, intragas-
tric administration of LAS. (39.5% active, hydrocarbon chain length range 
from 9-15 and nominally C12) to fasted Wistar-derived rats resulted in 
an LD50 of 650 mg/kg (Oser and Morgareidge, 1965). 
A number of studies have attempted to simulate continuous oral 
exposure to LAS through the chronic introduction of detergent formula~ 
tions into the diet or drinking water of test animals. Paynter and 
Weir (1960) employed LAS containing an alkyl radical that was 90% C11-
C13 and predominately the c12 homolog; the material was assayed as 
97-98.5 % pure. In a two year study, Carworth Farms' rats exhibited no 
abnormal effects from the daily ingestion of 2000 ppm LAS mixed with 
their food on a wt/wt basis. 
Bornmann and Loeser (1963) reported no harmful effects of LAS 
(51.2% active) when mixed into the drinking water of rats. This study 
. 
used surfactant concentrations of 100 ppm, approximating a daily con-
sumption of 2-3 mg LAS/day. 
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Except for a significant increase in liver wt/body wt ratios in 
female rats receiving 250 mg LAS/kg/day, no detrimental effects of sub-
acute administration of LAS were noted in weanling FDRL rats (Oser and 
Morgareidge, 1965). Comparable results were obtained by Kay et al., 
(1965) who introduced concentrations of 0.5% LAS into the diets of rats 
for 90 days. 
In recent years, investigations of LAS toxicity have shifted focus 
toward its potential interference with reproductive and developmental 
processes. CR-CD rats were given concentrations of LAS (C10-C14; 41% 
active; LD50 of 900 mg/kg) approximating 500 mg/kg/day for two years. 
No significant dietary-induced consequences were observed for either the 
original test animals or their offspring, who also received the LAS-
supplemented diet (Buehler et al., 1971). 
Another set of experiments (Mikami and Nagai, 1969) reported 
teratogenic results with surfactant administration to a variety of ver-
tebrates. In tests with ICR-CD-1 mice, Mikami found detrimental effects 
with topical (3% solutions) and oral (60 mg/kg) exposure to LAS. The 
abnormalities found included cleft palate, faulty eye, bone or organ 
formation, brain damage and death. Sakai (1973) subsequently reported 
that doses of LAS as small as 0.015 mg/kg were potent enough to cause 
malformations and retarded growth in mouse embryos when the surfactant 
was applied to the skin of pregnant females. 
Using NZW rabbits, CD rats and ICR-CD mice as subjects, Palmer 
and Readshaw (1973) also studied the teratogenic action of dermally 
applied LAS. Although rats and rabbits appeared quite resistant to such 
treatment, mice exhibited implantation losses of 80% at a dose level of 
500 mg/kg. The surfactant was applied as a 3% solution in a volume of 
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o.5 ml on days 2-13 of pregnancy, inclusive. These results ~uggested 
to Palmer and Readshaw that the toxic reaction to topically-applied LAS 
was primarily maternal and manifested in the embryo. 
A recent study (Palmer~ al., 1975) has reaffirmed the hypothesis 
that teratogenic actions of LAS are secondary to adult toxic responses. 
Rabbits, mice and rats (NZW, CD-1, CD strains, respectively) were gavaged 
with doses of LAS in concentrations of 0.2, 2, 300, or 600 mg/kg. In-
tubations were performed on days 6 through 18 of pregnancy for rabbits, 
days 6 through 15 for rats and mice. Rats exhibited slight maternal 
toxicity at 600 mg/kg as denoted by reduced weight gains, % litter loss 
including resorptions, or death. In contrast, rabbits and mice showed 
significant intolerance at both the 300 and 600 mg/kg doses. The least 
resistance towards LAS administration was found to occur in rabbits as 
evidenced by an implantation loss of 100% at the 300 mg/kg dose level; 
rats demonstrated the least sensitivity in all parameters assayed. 
Investigative work with the zygotes of zebra fish (Manner and 
Dewese, 1974) has revealed that only the early stages of embryonic cell 
division may be susceptible to teratogenic induction by LAS. Such an 
observation provides a research model to be substantiated or negated in 
mammalian systems in the present study. 
MATERIALS AND METHODS 
I. General Procedures 
A. The Animals: Forty-two day old ICR CD-1 mice were obtained 
from Charles River Breeding Laboratories, Wilmington, Massachusetts. 
Animals were maintained in the laboratory until studied, at ages 2~ -
5 months. They were housed in plastic shoe-box type cages containing 
SanicelR, an inert bedding material. Cages measured 8~llx6 inches and 
had a maximum density of 4 animals/cage. Throughout the study, the mice 
received Purina Mouse Chow for Breeding MiceR and distilled-deionized 
water ad libitum. Fresh water was supplied every other day; cages and 
water bottles were cleaned weekly. Room temperature was regulated at 
22 + 1° C under a 12 hour li~ht-12 hour dark photoperiod and a relative 
humidity of 50 + 10%. Access to the animal room was limited and back-
ground music employed to neutralize ambient noise levels. 
B. The Test Material: Linear alkylbenzene sulfonate (LAS) hav-
ing an average hydrocarbon chain length of 11.8 was provided by the 
Procter and Gamble Company, Cincinnati, Ohio. The test material was an 
off-white paste; its composition was assayed as 57.5% active sodium 
dodecylbenzene sulfonate, 0.91% sodium sulfate, and a remaining fraction 
of unreacted alkylbenzene and water. 
A correction factor of 1.74 was used in calculating doses to ad-
just the LAS administered to 100% activity. To prepare a selected dose, 
10 times the amount of LAS required was weighed into a sterile, plastic 
container; 2.5 ml of 0.9% physiological saline solution (PSS) was added 
and the suspension thoroughly mixed with a teflon-coated magnetic stirrer. 
13 
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Solutions were prepared separately for each mouse, except in those cases 
of equal weights. Accuracy was within 0.1 mg. To increase the precision 
of solution preparation for all dose levels less than 20 mg/kg, 100 times 
the test material to be administered was weighed and mixed with 25 ml of 
PSS. In the above cases, fresh stock solutions were prepared daily, 
based on the maternal body weight of the test animal receiving the high-
est concentration. Dilutions were made for all other experimental mice 
with the appropriate amount of PSS. Control animals received the vehicle, 
PSS; all injections were contained in a volume of 0.25 ml. The mode of 
dose administration was intraperitoneal injection to conform with the 
contract established with the Procter and Gamble Company. 
C. The Mating: A maximum of 4 females/male were placed together 
overnight. On the following morning, pregnancies were assumed on the 
basis of vaginal plugs and/or positive sperm smears (Green, 1966; Rugh, 
1968). When a mating was confirmed, this time was designated day 0 of 
gestation. 
II. Specific Procedures of Various Sections of the Study 
The original experimental design was to explore the effects of LAS 
and sodium sulfate at a low (5 mg/kg), a medium (150 mg/kg), and a high 
(300 mg/kg) dose level. However, alterations of that scheme were necess-
itated by the initial results obtained; the following methods evolved. 
A. "High" Dosag~ LAS and Sodium Sulfate: Fifteen pregnant mice 
were randomly separated into 3 groups and received 300 mg/kg LAS-PSS; 
300 mg/kg sodium sulfate-PSS; or the vehicle. Intraperitoneal injections 
were administered from day 0 through day 12 of gestation. This range of 
treatment days was employed to detect early resorptions. On day 13, the 
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females were killed with excess ether and the embryos necrospied follow-
ing the technique of Rugh (1968). 
B. Range Study .!· Implantation: Pregnant female mice received 
LAS-PSS in doses ranging from 0-300 mg/kg (30 mg increments). Intra-
peritoneal injections were administered from· day 0 through day 7 of 
gestation. On day 8, the females were killed with excess ether and ex-
amined for the presence of implants. 
C. Range Study 1_. Gestation: Intraperitoneal injections of LAS-
PSS were administerea to pregnant mice from day 0 through day 16 of 
gestation. Doses ranged from 0-45 mg/kg (5 mg increments). On day 17, 
females were etherized and Caesarian sections performed to remove the 
uteri containing embryos. Viability of fetuses was determined by prick-
ing the limbs. Fetuses were weighed in utero and examined for gross 
abnormalities (i.e~, non-symmetry of eyes, ears and limbs; distortions 
of snout, tail and overall proportions of body regions; an- and microph-
thalmia; exencephaly; meningoencephalocele; syn-, poly-, a-, and 
brachydactyly; micro-, and phocomelia; umbilical hernia; and spina 
bifida). Uterine positions and the number of implants and resorptions 
were recorded. One-third of the fetuses from each litter were cleared 
and stained in alcoholic KOH-alizarin red (Knudsen, 1966); these were 
examined for skeletal anomalies (i.e., symmetry, fusion and ossification 
of cranium, ribs, sternum, centra of vertebral column, vertebrae, limbs, 
digits). The remaining 2/3 of the fetuses were fixed in Bouin's fluid 
for at least 3 weeks; these were inspected for soft-tissue defects. In 
scoring these fetuses, the umbilicus was removed and the fetal volume 
recorded by fluid displacement in a graduated cylinder. Free~hand 
sectioning with a razor blade was then performed according to the 
16 
technique of Wilson (1965). 
The significance of any experimental differences was determined 
by Gossett's student "t" test which considers the variance present with-
in groups and the size of the sample (Sokal and Rohlf, 1969) and the 
Chi-square analysis which estimates the similarity of data presented 
as percentages (Senter, 1969). 
RESULTS 
A. "High" Dosage LAS and Sodium Sulfate: Maternal deaths occurred 
within 24 hours in all mice receiving 300 mg/kg LAS-PSS. The mice ex-
hibited strong, sustained abdominal contractions after the injection of 
the surfactant. No significant differences from control animals in sur-
vival rates or other litter parameters were found in the group which was 
administered 300 mg/kg sodium sulfate. 
B. Range Study .!.· Implantation: Maternal deaths were evidenced 
within 3 days in all groups given intraperitoneal injections exceeding 
45 mg/kg LAS-PSS. Both dams and embryos survived at dosages of 45 and 
30 mg/kg LAS with litter sizes equal to those of controls, although 
marked maternal contractions were observed within 30 seconds after the 
injections of LAS. 
C. Range Study l· Gestation: The results of the forgoing range 
study indicated that 45 mg/kg was the highest dose of LAS 'that would 
permit implantation to occur. However, as 2 of the 4 females treated at 
this level succumbed before day 17 of gestation, an additional range 
study was performed. Reduction of the dose level proceeded to 20 mg/kg 
in 5 mg/kg increments with embryotoxicity still in evidence (Tables l*-
3). The final doses selected for expansion were 5, 10, and 15 mg/kg. 
The results from treatment at these dose levels are shown in Tables 4-6. 
No significant differences were obtained between the control and the 5 
mg/kg groups except for the percentage of fetuses with skeletal varia-
tions {p < 0.05). In contrast, the 10 and 15 mg/kg animals were signi-
17 
* Tables include control values acquired concurrently with these experi-
mental groups. 
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ficantly lower than the controls in litter size of viable Y?ung, litter 
weights and fetal volumes (Table 4). These groups also showed signifi-
cantly greater resorptions and fetal deaths (Table 4), percentage of 
fetuses with visceral variations (Table 5) and percentage of fetuses with 
skeletal variations (Table 6). 
A tabulation of litter effects with LAS treatment is presented in 
Table 7. 
Significant increase (p <0.001) in both the number of fetuses 
affected (visceral or skeletal) and the number of fetuses resorbed or 
affected were found in all animals treated with LAS, except the 5 mg/kg 
group. These percentages and the original ratios are summarized in Table 
8. 
TABLE 1 
THE EFFECT OF LAS (20-45 mg/kg) UPON FETAL DEVELOPMENT 
Number of dams Average litter 
Dose bearing viable Number of size of viable 
mg LAS/kg loung complete young % Resorptions Average Average 
maternal Number of con- resorptions or (implants - and litter weight fetal volume 
body weight firmed pregnancies maternal deaths resorptions fetal deaths (gms) (ml) 
0 12/14 0 12.3 5.7 17.75 1.22 
20 2/2 0 2.5 78.0 5.82 1.07 
25 2/3 1 4.7 60.9 10.16 0.88 
30 4/4 0 7.0 46.7 11.33 0.93 
35 2/4 1 1.3 88.9 not determined 0.90 
40 4/4 0 4.0 66.7 9.56 0.87 
45 1/4 3 1.0 92.3 4.13 0.90 
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TABLE 2 
VISCERAL ANOMALIES OF FETUSES FROM DAMS RECEIVING LAS (20-45 mg/kg) 
Dose (mg/kg) 0 20 25 30 35 40 45 
Number of fetuses 104 3 9 24 4 16 2 
examined 
Total number of 3 4 2 9 3 11 2 
anomalies 
Number of fetuses 3 2 2 7 3 9 2 
affected 
Hydrocephaly 1 1 4 3 2 2 
Cleft Palate 1 1 5* 
Bladder Distention 1 4 
Intra-abdominal 2 
Hemorrhage 
Cryptorchism 2 1 1 1 
Ectoptic Kidneys 1 1 
* 4 values scored from the same litter. 
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TABLE 3 
SKELETAL VARIATIONS OF FETUSES FROM DAMS RECEIVING LAS (20-30 mg/kg) 
Dose 0 20 25 30 
Number of fetuses examined 43 2 5 2* 
Total number of variations 9 4 16 5 
Total number of fetuses affected 9 2 5 2 
14 Ribs 3 l' 2 
Phalanges and/or metacarpals, 1 4 2 
metatarsals unossif ied 
Major sternal variations 1 1 1 
Minor sternal variations 5 2 4 1 
Reduction of cranial ossification 5 l'. 
* value does not include 2 fetuses which disintegrated during clearing process. 
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TABLE 4 
THE EFFECT OF LAS (5-15 mg/kg) UPON FETAL DEVELOPMENT 
Number of dams 
Dose bea'J:ing viable Average litter 
mg LAS/kg young size of viable % Resorptions Average Average 
maternal Number of con- young (implants- and fetal litter weight fetal volume 
body weight firmed pregnancies resorptions) ± S.D. deaths + S.D. (gms) + S.D. (ml) ± S.D. 
0 18/22 12.2 + 2.1 7.1 + 7.7 18.1 + 4.0 1.18 + 0.17 
5 15/17 11.3 + 1.9 10.1 + 7.0 17.6 + 3.0 1.18 + 0.16 
10 19/25 10.5 + 2.4a 16.1 + 13.5a 15.6 + 2.9a i.06 + o.14b 
15 7/8c 8.3 + 2.7 d 29.6 + 25.5b 12.2 + 3.7b o.95 + o.16b 
a Significantly different from control values. by Gossett's Student-t test at p < 0.05. 
b Significantly different from control values by Gossett's Student-t test at p <0.001. 
c 1 maternal death (Day 14). 
d Significantly different from control values by Gossett's Student-t test at p <0.01. 
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TABLE 5 
VISCERAL ANOMALIES OF FETUSES FROM DAMS RECEIVING LAS (5-15 mg/kg) 
Number Total Number of % Intra-
Dose of fetuses number of fetuses affected Hydro- Cleft Bladder Abdominal Crypt-
mg/kg examined anomalies affected fetuses cephaly Palate Distention Hemorrhage or ch ism Other 
0 152 6 6 4.0 2 1 1 0 2 0 
5 114 3 3 2.6 1 1 0 1 0 0 
10 133 20 19 16.8* 14 0 4 1 1 0 
15 37 17 11 29.7* 7 2 0 1 5 2** 
* Significantly different from control values by the Chi-square test at p < 0.001. 
** 1 hare-lig; 1 folded retinae. 
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TABLE 6 
SKELETAL VARIATIONS OF FETUSES FROM DAMS RECEIVING LAS (5-15 mg/kg) 
Dose (mg/kg) 0 5 10 15 
NUlllber of fetuses examined 67 55 66 21 
Total number of variations 45 38 107 51 
NUlllber of fetuses affected 29 31 48 21 
% affected fetuses 43.3 56.4a 72. 7b loob 
14 ribs 9 11 24 5 
Phalanges and/or metacarpals, 10 0 25 18 
metatarsals unossif ied 
Major sternal variationsC 3 2 9 5 
Minor sternal variationsd 22 22 27 16 
Reduction of cranial ossifi- 1 3 17 5 
cation 
Unossified caudal vertebrae 0 0 5 0 
Fused, missing ribs 0 0 0 1 
Vertebral centra "dumbbell"- 0 0 0 1 
shaped 
a Significantly different from control values by the Chi-square test at 
p < 0.05. 
b Significantly different from control values by the Chi-square test at 
p < 0.001. 
c Includes fetuses with missing, reduced ossification and/or non-fusion 
of 4 or more sternebrae. 
d Includes fetuses with missing or reduced ossification (usually the 
5th) and/or non-fusion (typically the 6th) of 1-3 sternebrae. 
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TABLE 7 
TABULATION OF LITTER EFFECTS 
Number of 
affected litters 
total number 
multiple variations of litters 
Number of 
litters with 2 
fetuses with the 
same variation 
a 
b 
0 
0 
1 
4 
13 
7 
31 
21 
5/18 
3/15 
13/19 
6/7 
12/18 
12/15 
16/19 
7/7 
1 
0 
2 
3 
4a 
8b 
9c 
4e 
Reflects 2 litters also tabulated in last column. 
Reflects 1 litter also tabulated in next column. 
Number of 
litters with 3 
fetuses with the 
same variation 
0 
0 
1 
0 
lb 
3b 
7d 
5b 
c Reflects 2 litters tabulated in next and 1 litter tabulated in last column. 
d Reflects 4 litters also tabulated in last column. 
e Reflects 3 litters also tabulated in next column. 
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·Number of 
litters with 4 
fetuses with the 
same variation 
0 
0 
0 
0 
4 
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6 
1 
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TABLE 8 
RANGE STUDIES 1 & 2: SUMMARY CHART 
Total number 
of fetuses Total number 
affected of.fetuses 
(visceral resorbed 
and skeletal) and affected Total % 
total number Total % total number res orbed 
examined variations of implants and affected 
35/219 16.0 51/235 21. 7 
34/169 20.1 53/188 28.2 
67/199 33.7* 105/237 44.3* 
32/58 55.2* 60/86 69.8* 
4/5 80.0* 23/24 95.8* 
7/14 50.0* 31/38 81.6* 
9/26 28.9* 32/49 65.3* 
3/4 75.0* 38/39 97.4* 
9/16 56.3* 33/38 86.8* 
2/2 100.0* 26/26 100.0* 
* Significantly different from control values by the Chi-
square test at p 0.001. 
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DISCUSSION 
" ••• if we do not sufficiently respect the intrinsic !ability of 
developmental processes, we are going to be deceived time and again into 
thinking that something we have done is always responsible for the 
differences that may occur among groups of differently treated animals" 
(Kalter, 1965). 
In this research, a potential mammalian teratogen, linear aklyl-
benzene sulfonate, was introduced via intraperitoneal injection to preg-
nant ICR CD-1 mice. The effects of such treatment on fetal development, 
including the differences obtained at various dose levels, have been 
appraised through a number of parameters, which collectively provide a 
coherent interpretation for the results obtained •. The separate examina-
tion of these values, as well as the role of variables present within the 
experimental design, originate with some assumptions and definitions from 
the field of teratology. 
A. Principles of Teratogenesis: Teratology is a study of the 
"causes, development and anatomy of morphologically abnormal individuals" 
(Dagg, 1966). An interference with normal embryonic development occurs 
through the interaction of three major components, which vary in their 
degrees and modes of expression for each individual pre-natal experience. 
The first consideration is the genetic make-up of both the mother 
and the developing organism (Runner, 1965; Wilson, 1965; Wilson, 1973). 
In the present experiment, genetic homogeneity was maximized through the 
use of an inbred strain of mice (Gruneberg, 1963; Smithberg, 1967). This 
procedure allows a more uniform response to a teratogen, thereby increas-
ing reproductivity, although it also decreases the normal variability of 
genetic pools. 
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A second set of factors which determines susceptibility toward a 
teratogen are the physical conditions of the environment. Some variables 
are conducive to control (e.g., lighting, temperature, humidity, nutrition, 
age and parity of mother) (Kalter, 1965; Wimer and Fuller, 1966); others 
which involve experimental manipulation are. ·more difficult to regulate 
{e.g., handling of animals during injections and weighings, seasonal and 
circadian body rhythms) (Harnly et al., 1970; Brown et al., 1972; Haus et 
al., 1974; Halberg, 1974). The interplay of embryonic and maternal sen-
sitivity with such physical factors is unique and opposes experimental 
management. 
· In addition to the spectra of physiological and environmental ab-
errations which can alter the effects of a teratogen, a third source of 
variability is the process of development itself. The conceptus experi-
ences a range of sensitivities during its uterine existence. While many 
advances have been made in determining "peaks of susceptibility" towards 
teratogenic agents, the individual's response to any external operator is 
consistently singular (Rugh, 1964; Wilson, 1965; Green, 1966; Smithberg, 
1967). 
The propriety of relating non-human, and particularly, sub-primate 
research to human teratology has been contested in the literature as well 
as the laboratory (Lenz, 1966; Wilson, 1973; Sullivan, 1974). There is 
no question that species differ in their responses to the same teratolog-
ical agent (Lenz, 1966; Posner, 1972); even strains within the same species 
show significant variations (Trasler, 1965; Smithberg, 1967; Brown et al., 
1972). Brent (1974) has suggested that in some cases, the deviations 
which exist between mice and rats are greater than the differences which 
occur between mice aod humans. 
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Several workers have elaborated upon the inequality of ·human pla-
cental morphology when compared to the typically-used laboratory orders, 
the rodents and lagomorphs. While the former has a haemochoriad chor-
io-allantoic placenta, the latter, at least towards the end of gestation, 
possess haemoendothelial ones (Amoroso, 1952; Bellairs, 1971). Theim-
portance of this difference has been denied by Dawes (1968) ~ho suggests 
that the number of cell layers separating maternal and fetal circulation 
is less critical than the thickness and transport efficiency of the layers 
involved, which is probably comparable in both types. 
Another morphological difference of placentation between mice and 
humans is the mouse's possession of a complete inverted-yolk sac placenta 
which is functional until the tenth day of pregnancy (Amoroso, 1952; 
Bellairs, 1971; Lindquist and Ullberg, 1971; Wilson, 1973). This yolk sac 
placenta is the only extraembryonic tissue in the rodent that is capable 
of breaking down macromolecules to any extent (Lindquist and Ullberg, 1971) 
; the endodermal cells selectively absorb protein and glycoprotein sub-
stances, presumably for storage (Haar and Ackerman, 1971). The possibil-
ity exists that absorption of teratological agents can either be hindered 
(e.g., chemical breakdown, Bellairs, 1971) or facilitated (e.g., an in-
hibition of embryotrophic nutritional enzymes,(Lindquist and Ullberg, 1971) 
through this route prior to the assumption of the absorptive role by the 
chorio-allantoic placenta. 
The importance of this alteration in source of intra-uterine nutri-
tion in the mouse fetus may account, in part, for the differences in the 
results reported here (chronic dosage from Day 0 of gestation to Day 17) 
and those found by Palmer~ al. (1975) who administered LAS from Day 6 
of gestation through Day 15, although the method of administering LAS 
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cannot be over-looked also. 
B. Physiological Interactions of Surfactants: Since so many 
variables alter their relationships throughout the intra-uterine period 
of development and since only gross observations were made from this study, 
a molecular model for possible courses of LAS action during gestation can 
only be founded on the general chemical properties associated with de-
tergents in solution. 
As early as 1959, Lish and Weikel showed that anionic, but not non-
ionic, surfactants increased the absorption rate of materials from the 
rat colon. Levy and Reuning (1964) found that various drugs, in the 
presence of detergents, would form complexes which altered their rates of 
absorption in the rat. These complexes (mixed micelles) were suggested 
to involve endogenous bile salts in the intestinal absorption of drugs 
(Utsumi ~al., 1974) and to depend on both pH and the polarity of the 
surfactant head group for the mode of interaction (Aoki and Hori, 1959; 
Blinkhorn and Jones, 1973). Michael (1968) found that with oral adminis-
tration of LA35s into male rats, less than 0.1% of the dose was detectable 
in the body after 72 hours; 60-65% of the metabolites were excreted in 
the urine and the remaining 35% were found in the bile. 
In the field of membrane research, detergent addition was demon-
strated to alter the charge of artificial lipid bilayer membranes (Seu-
fert, 1973). For non-ionic surfactants, the polarity change was tran-
sient but with LAS and other anionic detergents, the membrane was perma-
nently affected. Later _studies suggested that anionic surfactants 
increased the solubility of membrane proteins by replacing, wholly or in 
part, the lipid component (Tanford ~al., 1974). Concurrent "with these 
findings, Nilsson et al (1973) demonstrated that there was a decrease in 
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negative charge on the membranes of mouse blastocysts which had become 
activated for implantation. The authors suggested that this alteration 
was related to the increased adhesiveness of the trophloblast cells 
necessary to establish contact with the uterine epithelium. 
Yang and Foster (1953) demonstrated statistical and all-or-none 
binding to ovalbumin and albumin by LAS; the protein-lipid complex was 
assayed as more stable than the pure lipid micelles (Reynolds and Simon, 
1974). A shortening of surfactant chain length was shown to decrease 
binding affinity for the unfolded albumin, but not for the native protein 
(Steinhardt et al., 1974). 
Detergents, as might be expected, also interact with enzymes. Al-
though non-ionic surfactants demonstrate no binding affinity to ribonu-
clease A, anionic detergents will inhibit or promote RNA polymerase 
activity in mouse mitotic cells, depending on the polarity of the head 
group (Jones et al., 1973; Garriglio et al., 1974). Further, the struc-
tural identity of such compounds can enhance or inhibit the enzymatic 
reaction of membrane-bound brain neuraminidase upon gangliosides (am~ 
phipathic substances) (Tettamani et al., 1974). 
Such examples from the literature are not intended to define the 
method of interaction of LAS as a teratogenic agent. But by a presentation 
of some of the known mechanics of molecular reactions of anionic detergents 
with physiological systems, it is shown that a number of interacting sites 
for interference with development do exist which will be further elucidated 
in the following section. 
C. Development: Mechanisms and Alterations: Of particular inter-
est, then, is a resolution of the mode/modes of interference upon develop-
ment displayed by LAS' administration. 
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1. Viability: A comparison of resorption and fetal death rates 
of the control animals (7.1%) with the LAS-treated groups (Table 4) dem-
onstrated a consistent rise from the 5 mg/kg dose (10.1%) to the 10 mg/kg 
level (16.1%; p 0.05) and the 15 mg/kg group (29.6%; p<0.001). In 
addition, fetal deaths and resorptions ranged from 46.7% (30 mg/kg) to 
92.3% (45 mg/kg) for all doses exceeding 15 mg/kg in which implantation 
occurred (Table 1). Such values indicate that LAS dosage and viability 
are inversely related. The lack of implantation above doses of 45 mg/kg 
further substantiates this view and is similar to the adverse effects of 
orally administered LAS upon litter viability in mice and rabbits (Palmer 
et al., 1975). 
2. Organogenesis: A second observation from the·data (Tables 
2,3,5,6) is that with increased LAS dosage, a higher number of fetuses 
exhibited visceral and skeletal deviations. Although some teratologists 
regard bladder distention and intra-abdominal hemorrhage as minor visceral 
anomalies which occur spontaneously in mice (0.51%; 1.36%, respectively) 
(Palmer, 1972), other experts consider distention of the bladder to be a 
"physiological variant" while intra-abdominal hemorrhages are associated 
with rupture of umbilical veins during retrieval of the fetus from the 
uterus (Wilson, 1975, personal communication). 
Such examples demonstrate the illogical assumption that all varia-
tions of development are necessarily related to the administration of a 
potential teratogen. In their assessment, therefore, such deviations must 
be considered on the basis of their frequency as well as the presence of 
other malformations which may contribute to a pattern of developmental 
interference (Smithberg, 1967; Palmer, 1972). In the data obtained in 
this experiment, the rising incidence of these "normal" physiological 
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variants, coupled with a greater occurrence of observed visceral malfor-
mations and skeletal variations, is positively related to an increase in 
LAS dosage and significantly so at concentrations exceeding 5 mg/kg. 
It has been suggested (Gruneberg, 1963; Fraser, 1971) that the 
processes of organogenesis exhibit threshold characteristics. Develop-
mental aberrations are the result of multifactorial variables in the 
genome and the environment which do not permit one or more of the thres-
holds to be reached. The concept of thresholds is applicable to the re-
sults of LAS treatment upon the maturing organism. 
a. Cleft Palate: In oral-facial development, palate formation 
is the result of fusion of the palatine shelves (Gray, 1936; Langman, 1969). 
These shelves are outgrowths of the maxillary sw~llings which are first 
situated obliquely, but re-orient their positions horizontally as the 
tongue is displaced downward (Fraser, 1968; Langman, 1969). The shelves 
eventually approach each other and fuse, forming the secondary palate; 
additional anterior fusion occurs to join the secondary palate to the 
primary palate at the point of the incisive foramen (Gray, 1936; Langman, 
1969). A failure of the palatine shelves to fuse posterior to the in-
cisive foramen constitutes a secondary cleft palate (Langman, 1969) of 
the type produced by this study. Several hypotheses exist to account for 
this malformation which occurs spontaneously in mice (46.6%) (Palmer, 
1972) and demonstrates strong litter bias (Fraser, 1968; Palmer, 1972). 
One suggestion is the presence of excess fluid in the tissues which 
surround the shelves, which fluid creates abnormal pressure to inhibit 
closure (Posner, 1972). Another idea involves the situation of too little 
amnionic fluid with subsequent compression of 
veloping shelves (Fraser, 1968). A different hypot 
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growth produces changes in shelf movement forces (Fraser, 1968); inhi-
bition of mitotic activity (e.g., some anionic surfactants' effect on 
RNA polymerase A) could delay or obscure such a mechanism (Jones et al., 
1973; Garriglio et al., 1974). 
Fraser (1968) has noted that acid mucopolysaccharides are important 
in the formation of a supporting framework for palatine shelf closure. An 
inhibition of acid mucopolysaccharide synthesis (Fraser, 1968) or an in-
sufficient amount of collagen cross-linking in this region (Posner, 1972) 
might also induce cleft palate. The demonstrated interference of surfac-
tauts with protein-lipid binding (Tanford et al., 1974; Tettamani et al., 
. 
1974) is consistent with these suggestions. 
b. Hydrocephalus: In this study, the majority of the hydro-
cephalus produced involved the fourth ventricle; the lateral ventricles 
were moderately enlarged and in some cases, the third ventricle was also 
expanded. Hydrocephalus can result from an overproduction of cerebro-
spinal fluid (CSF) by the choroid plexuses, an obstruction of CSF passage 
from the ventricles, or a defective CSF absorption pathway (Browne, 1967; 
Cizek, 1968; Fishman, 1971; Gruneberg and DeWickramaratne, 1974; Foley, 
1974). The excess CSF in the ventricles results in the expansion of their 
walls; the amount of dilation depends upon the pressure gradient thus 
produced (Geschwind, 1968; Fishman, 1971). In Browne's etiology, the 
interference of CSF circulation is interpreted as the result of increased 
spatial pressure, which induces restrictions on the expanding nervous 
system. 
Lorenzo and Spector (1973) reported that salicylates could alter the 
acid balance of brain metabolism by competing with the organic acid 
transport system of the choroid plexus. In addition, Fishman (1971) noted 
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that hydrocephalus arising from deficient CSF absorption was accompan-
ied by an increase in CSF protein. These observations may have s.ome 
bearing on the mechanism of LAS-related hydrocephalus involving increased 
protein solubility with polarity group- and pH-dependent properties (Aoki 
and Hori, 1959; Utsumi £!al., 1974; Tanford· et al., 1974). 
c. Cryptorchism: Gier and Marion (1970) have described the 
type of testicular descent characteristic of Rodentia which differs from 
other mammals (e.g., primates). In the mouse, although the mechanisms 
for the descent of the testes must be established before movement begins, 
the actual passage to the scrotum from the peritoneal cavity does not 
occur·until several days after birth (Gier and Marion, 1970). In this 
study, then, cryptorchism was scored as a placement of the gonads anter-
ior to the bladder and nearer the kidneys (Wilson, 1965; Palmer, 1972). 
The concept c:if "time of delay" (Fraser, 1971) representing a crit-
ical threshold in testicular descent agrees with the opinion of Gier and 
Marion (1970) that cryptorchism is due to late closure of the umbilical 
canal with a subseq~entstrengthening of the inguinal area, inhibiting 
any later passage of the testes. 
d. Ossification: Data of Tables 3 and 6 indicate that skeletal· 
variations induced by LAS-treatment primarily involve reduced ossifica-
tion of metacarpals, metatarsals, phalanges and sternum. Grunebert (1963) 
reported that disorders of the osseous skeleton can sometimes be traced 
to a prior involvement of the cartilagenous skeleton, and perhaps even 
further to include the blastemal condensations composing the membranous 
skeleton of development in the mouse and other animals. Since the present 
reduction of ossification might result from a retardation of cartilage-
nous or membranous skeletal formation, some characteristics of these 
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network formations will be considered. 
Forsthoefel (1963) noted that the post-axial blastemal condensa-
tions preceeded those of the pre-axial ones in his enumeration of se-
quential events occurring in mouse limbs. In this view, variations of 
skeletal formation are usually restricted to the pre-axial bones (Fors-
thoefel, 1963). In contrast, Singh and Sanyal (1974) using cyclophos-
phamide (a compound which supresses cell division in mesenchymal tissue), 
have shown that the pre-axial bones differentiate first. This study also 
demonstrated the transient phase of ossification in development (Palmer, 
1972), since fetuses collected later in pregn&ncy showed significant re-
covery and repair from the administered drug (Singh and Sanyal, 1974). 
It is probable that some of the variations in skeletal ossification of 
LAS-treated animals would also disappear with further maturation. 
Biochemical studies have revealed some of the kinetics of cartilage 
formation; the condroitin sulfate-protein complex was found to dissociate 
in alkaline solutions, implying covalent linkage within the matrix 
(Partridge and Elsden, 1961). Bhatnager and Prokop (1966) found that 
complexes between collagen and sulfated mucopolysaccharides were not 
necessary for matrix formation; however, a later study has shown that 
only the synthesis of chondroitin sulfate, and not matrix deposition, is 
independent of protein collagen (Lavietes, 1971). 
DeLuca et al (1973) demonstrated all-or-none binding character-
- -
istics in the sulfation.of chondroitin; Shapiro and Sherman (1974) did 
not find significant incorporation of labeled sulfate into mucopoly-
saccharides until the tenth day of gestation in the mouse. This study 
also indicated that the yolk sac· absorbed much less (20%) of the label, 
while the trophloblast and decidua differed from the embryo proper in 
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the position of mucopolysaccharide sulfation. All of the latter tissues 
incorporated comparable amounts of the labeled sulfate (50%) ·(Shapiro 
and Sherman, 1974). 
The above studies suggest that retarded ossification from LAS treat-
ment could be the result of an inhibited complex formation of the carti-
lage matrix or an alteration of yolk sac absorptive capacity (Yang and 
Foster, 1953;·Levy and Weikel, 1964; Bellairs, 1971; Lindquist and Ull-
berg, 1971; Tanford ~al., 1974). 
Another possible mechanism of interference with cartilage and bone 
calcification (Harper, 1969) is the property of detergents to bind with 
free calcium ions forming insoluble soaps which decreases the critical 
ratio of calcium to phosphorous necessary for bone ossification (Harper, 
1969; Hart and Schuetz, 1972; Morrison and Boyd, 1972). 
3. Growth: Fetal growth in this study was assayed through the 
displacement of fluid in a graduated cylinder. Since the volume of all 
fetuses was thus obtained from specimens preserved in Bouin's for a min-
imal time of 3 weeks, it is assumed that any shrinkage due to the process 
of fixation was constant and the values obtained represent real differ-
ences. Significant decreases in fetal volume were found in all LAS-treated 
groups (except 5 mg/kg) and were inversely related to increased LAS do-
sage (Tables 1,4). 
Brent and Jensh (1967) have classified drugs into one of 4 groups: 
Type I are the classical teratogens producing a specific effect or syn-
drome in the experimental animal and deleteriously affecting growth; 
Type II are the drugs which are less specific in their embryological 
effects on both growth and development. Type III consists of the non-
teratogenic drugs which produce retarded growth and Type IV are the 
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drugs which do not affect growth or development of the un-born. 
In such a classification, it is probable that LAS falls between 
the Types II and III, tending to produce teratogenesis and growth re-
duction at higher doses, and having its primary effect on growth rates 
at the lower ones (Brent and Jensh, 1967). 
The patterns of intra-uterine growth retardation have been inves-
tigated {Eckstein and McKeown, 1955; Eckstein~ al., 1955; Brent and 
Jensh, 1967; Dawes, 1968; Brent, 1974). It is generally accepted that 
the rate of blood flow through the placenta is a critical factor in 
growth, both in supplying oxygen and nutrients and in removing waste 
products which can inhibit growth if accumulated. Such a flow of pla-
cental fluid is subject to considerable variation from the physical 
factors of pregnancy {e.g~, size of litter, placentae, fetuses; fetal 
distribution between uterine horns; and maternal health) (Eckstein and 
McKeown, 1955; Eckstein et al., 1955; Brent and Jensh, 1967; Browne, 
1967; Dawes, 1968; Brent, 1974). 
In addition to such mechanical factors, the transport of substances 
across the placenta is regulated by the molecular composition of the 
transferred substance (Villee, 1965; Shah et al., 1973); em:logenous ele-
ments of the placental surface cells may also play a role (Villee, 1965; 
Shith et al., 1974). 
Since the potential interference with growth rate can occur from 
implantation to parturition, while teratogenic effects are usually re-
stricted to the organogenetic period (1/3 of the gestation time of mice), 
Brent (1974) has suggested that intra-uterine growth retardation offers 
a more sensitive measure of adverse environmental conditions than malfor-
mation. This concept concurs with the results obtained from this study 
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of chronic LAS dosage, whereby a significant reduction of growth was 
paralleled by an increase in visceral and skeletal variations. These 
organogenetic effects could be due to a slower maturation rate of pre-
liminary processes in concert with an over-all growth retardation, with 
the subsequent failure to meet the thresholds for proper formation 
(Gruneberg, 1963; Fraser, 1968; Gier and Marion, 1970; Fraser, 1971; 
Shapiro and Sherman, 1974; Gruneberg and DeWickrarnaratne, 1974). 
Beck and Lloyd (1963) found that as pregnancy proceeded in rats, 
the number of malformations decreased while the resorption rate increased. 
They suggested that intra-uterine death was the secondary response to a 
pre-existing malformation. In this study, both the significant decrease 
in viability above the 5 mg/kg level and the lack of implantation above 
a dose of 45 mg/kg, correspond to this hypothesis. Further, the retarded 
growth and increased organogenetic aberrations of the LAS-dosed mice in-
dicates that at higher concentrations of this surfactant, the adverse 
environmental conditions may produce individuals too malformed to sus-
tain intra-uterine existence. 
D. Experimental Considerations: This study engendered several 
problems which may have influenced the type of results obtained. In the 
long search for a dosage which was not maternal and/or ernbryotoxic, sev-
eral shipments of mice were required. This introduced variables as to 
inter-strain sensitivities toward LAS administration as well as seasonal 
differences in mating potential. One example of this variable sensitiv-
ity is demonstrated from the 10 mg/kg group data (Table 4). In the time 
period from November 29-December 27, of the 12 females who exhibited 
signs of fertilization (11 with vaginal plugs), 6 did not implant and 1 
had a total litter size of 7 (average implant size was 12-13). This 
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lower pregnancy rate may indicate that a selective pattern was in opera-
tion which pe~itted only the more resistant females to implant. 
Another point of non-conformity with the experiment involves the 
dosing procedure. Some injections of the mice (approximately 5%) did 
not penetrate the abdominal muscles, resulting in sub-cutaneous or intra-
muscular rather than intraperitoneal injections. These cases of inaccur-
acy altered the route oj LAS circulation and metabolism; however, no 
cor.relation of these events was found within the data. 
One variable which was not controlled in this study was the timing 
of treatment with circadian body rhythms (Haus et al., 1974; Hallberg, 
1974). The effects of an unfixed time for dose administration are un-
known. 
A final point of interest is the maternal abdominal contractions 
which occurred after injection of LAS. Orentlicher et al. (1974) have 
found calcium interactions of detergents with muscle fibers; Villee 
(1965) and Browne (1967) have discussed the effects of mechanical fac-
tors and uterine contractions upon normal development. The application 
of such views to the observed maternal reaction remains to be investi-
gated. 
E. Ecological Applications: Wedell (1966) measured the amount 
of ingestion of LAS from unrinsed tableware to be approximately 0.4 mg/ 
day/person. Further, an estimation of the average total intake of sur-
factants is a range from 0.3-3 mg/person/day (Swisher, 1968). The work 
of Michael (1968) demonstrated that LAS is metabolized readily in rats 
with less than 0.1% of a 40 mg/kg dose detectable after 3 days. 
Such studies indicate that the minute amount of LAS ingested poses 
no threat through accumulation within body tissues. David (1975) has 
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recently shown no teratogenic potential of orally administered LAS in 
ICR CD-1 mice at concentrations as high as 225 mg/kg. The evident 
difference in the present study from David's is the method of surfactant 
administration. Gale (1974) has reported that intraperitoneal injection 
is the most potent route of entry in producing embryopathic effects when 
compared to.gavage, sub-cutaneous and intravenous injections. 
It can be concluded then, that although intraperitoneal injections 
of LAS produce growth retardation and subsequent teratogenic effects in 
doses greater than 5 mg/kg, and a loss of implantation above concentra-
tions of 45 mg/kg, the current levels of this·surfactant in the environ-
ment as well as the less potent mode of its ingestion, constitute no 
threat to organisms developing in utero. 
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